Skip to content
Agios to Present at the Cowen 40th Annual Healthcare Conference on Tuesday, March 3, 2020
CAMBRIDGE, Mass., Feb. 18, 2020 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company is scheduled to present at the Cowen 40th Annual Healthcare Conference in Boston on Tuesday, March 3, 2020 at 11:20 a.m. ET. A live webcast of the presentation can be accessed under
18.02.2020
G1 Therapeutics to Participate in BTIG Targeted Therapeutics Conference on February 24, 2020
RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Medical Officer Raj Malik, M.D., will participate in the “Breast Cancer – The Moving Landscape” panel discussion at the BTIG Targeted Therapeutics Conference. The conference will take place on Monday, February 24, 2020 at the St.
18.02.2020